Live Chart
O 0
H 0
L 0
VOL 0
Aspira Pathlab & Diagnostics Overview
Days Range
Previous Close
₹35.44
Open
₹34.20
Volume
1,745
Day’s Range
₹33.67 - ₹35.45
52W Range
₹22.76 - ₹49.50
Market Cap
₹36.48 Cr
Fundamentals of Aspira Pathlab & Diagnostics
| ROCE (TTM) | NA |
| P/E Ratio (TTM) | NA |
| P/B Ratio | NA |
| Industry P/E | NA |
| Debt to Equity | NA |
| ROE | NA |
| EPS (TTM) | NA |
| Dividend Yield | NA |
| Book Value | NA |
| Face Value | NA |
Financials of Aspira Pathlab & Diagnostics
Financials data is not available for Aspira Pathlab & Diagnostics. Please visit after some time.
About Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd, 1973. The Company is engaged into the business of running, owning, managing and administering Diagnostics Ce ... Read More
Parent Organisation
Indian Private
Founded
1973
Managing Director
Haseeb Drabu
NSE Symbol
NA
Peer Comparison
| Stocks | Market Cap (cr) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Aster DM Healthcare Ltd | ₹16,251.66 |
330.7 4.85 (1.49%) |
324.3 - 332.8 |
| Opto Circuits (India) Ltd | ₹53.51 |
1.8 0.00 (0.00) |
1.8 - 1.85 |
| Indraprastha Medical Corporation Ltd | ₹1,460.30 |
161.1 1.45 (0.91%) |
156.5 - 161.6 |
| Krsnaa Diagnostics Ltd | ₹2,042.73 |
650.25 2.35 (-0.36%) |
640.9 - 657.45 |
| Vijaya Diagnostic Centre Ltd | ₹4,752.37 |
455.6 10.05 (-2.16%) |
453 - 467.55 |
What's Trending
FAQs
What is the Share price of Aspira Pathlab & Diagnostics ()?
Aspira Pathlab & Diagnostics () share price as of September 22, 2023, on BSE is Rs 34.89 (BSE).
Can I buy Aspira Pathlab & Diagnostics () shares?
Yes, You can buy Aspira Pathlab & Diagnostics () shares by opening a Demat account with Angel One.
How do I buy Aspira Pathlab & Diagnostics () from Angel One?
Aspira Pathlab & Diagnostics () share can be brought through the following modes:
- Direct investment: You can buy Aspira Pathlab & Diagnostics () shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Aspira Pathlab & Diagnostics () shares.
